HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

cemadotin (LU 103793)

a synthetic derivative of dolostatin 15; interacts with microtubules & inhibits mitosis; structure in first source
Also Known As:
LU 103793; LU-103793; LU103793; N,N-dimethyl-L-valyl-L-valyl-N-methyl-L-valyl-L-prolyl-L-prolinebenzylamide; NSC 669356D; NSC D-669356; NSC D669356; NSC-669356D; NSC-D669356
Networked: 10 relevant articles (0 outcomes, 8 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Wanders, J: 2 articles (02/2003 - 04/2001)
2. Anishetty, Sharmila: 1 article (05/2014)
3. Jayakumar, Jayanthi: 1 article (05/2014)
4. Lopus, Manu: 1 article (10/2013)
5. Atheaya, Himanshu: 1 article (01/2006)
6. Joshi, Mukesh C: 1 article (01/2006)
7. Joshi, Penny: 1 article (01/2006)
8. Rawat, Diwan S: 1 article (01/2006)
9. Addo, Ferdinand: 1 article (08/2003)
10. Fishkoff, Steven: 1 article (08/2003)

Related Diseases

1. Neoplasms (Cancer)
2. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
3. Breast Neoplasms (Breast Cancer)
4. Melanoma (Melanoma, Malignant)
5. Hypertension (High Blood Pressure)

Related Drugs and Biologics

1. dolastatin 15
2. cemadotin (LU 103793)
3. Peptides (Polypeptides)
4. Antimitotic Agents
5. tasidotin
6. hemiasterlin
7. soblidotin (TZT 1027)
8. plitidepsin (aplidine)
9. kahalalide F
10. didemnins

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)